[1]张福奎, 贾继东, 王宝恩, 等.45例原发性胆汁性肝硬化的临床特征[J].中华内科杂志, 2002, 41 (3) ∶163-167.
|
[2]JamesOF , BhopalR , HowelD , etal.Primarybiliarycirrhosisoncerare, nowcommomintheUnitedKingdom[J].Hepatology, 1999, 30 (2) ∶390-394.
|
[3]SorenHT , ThulstrupA , FriisS , etal.Cancerriskinpatientswithlivercirrhosis:Aregistrystudybasedon850000personyears[J].JHepatol, 1997, 26 (suppl1) ∶101-106.
|
[4]HeathcoteEJ .Managementofprimarybiliarycirrhosis.TheAmericanAssociationfortheStudyofLiverDiseasespracticeguidelines[J].Hepa tology, 2000, 31 (4) ∶1005-1013.
|
[5]姚光弼.重视原发性胆汁性肝硬化的临床研究[J].中华肝脏病杂志, 2002, 10 (5) ∶325-326.
|
[6]阎惠平, WinfriedSt cker, 贺立香, 等.不同肝病患者抗肝抗原自身抗体的研究[J].中华微生物和免疫学杂志, 2002, 22 (5) ∶522-525.
|
[7]KimWR , Ludwig, LindorKD .Variantformsofcholestaticdiseasesin volvingsmallbileductsinadults[J].AmJGastroenterol, 2000, 95 (5) ∶1130-1138.
|
[8]LeungPS , VandeWaterJ, CoppelRL , etal.Molecularaspectsandthepathologicalbasisofprimarybiliarycirrhosis[J].JAutoimmun, 1996, 9 (2) ∶119-128.
|
[9]王吉耀, 蒋炜, 高虹, 等.原发性胆汁性肝硬化的临床及病理学特征[J].中华肝脏病杂志, 2002, 10 (5) ∶334-337.
|
[10]姜小华, 仲人前, 胡寅, 等.用重组M2三联体抗原建立原发性胆汁性肝硬化免疫检测法[J].中华检验医学杂志, 2002, 25 (2) ∶75-77.
|
[11]张福奎, 贾继东, 钱林学, 等.抗线粒体抗体阴性原发性胆汁性肝硬化的临床特征[J].肝脏杂志, 2002, 7 (3) ∶150-152.
|
[12]姜小华, 仲人前, 安峰, 等.人源M2抗原检测M2抗体诊断抗线粒体抗体阴性原发性胆汁性肝硬化[J].中华风湿病学杂志, 2003, 7 (1) ∶7-9.
|